Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Oct 2021| HLC176D| BCC Publishing
Sample Report

Report Highlights

The global radiopharmaceuticals and therapeutics market should reach $28.5 billion by 2026 from $18.2 billion in 2021 at a compound annual growth rate (CAGR) of 9.4% for the forecast period of 2021 to 2026.

Report Includes

  • 52 data tables and 72 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals, and nuclear medicines
  • Estimation of the market size and analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, with projection of CAGR through 2026
  • Analysis of new opportunities, challenges, and technological changes within the industry and highlights of the market potential by type, method, technology, application and region
  • Assessment of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players in the market, including Accuray Inc., Bayer Pharma AG, Cardinal Health, General Electric Co., Nordion Inc. and Siemens Healthineers AG

Report Scope

This report examines the current and forecasted market potential of radiopharmaceuticals and therapeutics. It offers a detailed analysis of the technological advancement, competitive environment, market background, drivers and restraints, and market growth trends. The research report also includes market projections to 2026. The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2021 to 2026 are provided for each segment and regional market, with estimated values derived from manufacturers’ total revenues.

The report also includes a discussion of the major market players in radiopharmaceuticals and therapeutics. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.

By geography, the radiopharmaceutical and therapeutics market has been segmented into Europe, North America, Asia-Pacific (APAC) and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, France, Japan, India and China are covered in regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets219 $5,500 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights4$250Free
Chapter- 3: Regulatory Scenario3$75Free
Chapter- 4: Radiopharmaceuticals and Therapeutics: Background20$502Free
Chapter- 5: Market Dynamics25$628Free
Chapter- 6: Impact of COVID-19 Pandemic4$100Free
Chapter- 7: Market Breakdown by Type24$603Free
Chapter- 8: Market Breakdown by Production Method9$226Free
Chapter- 9: Market Breakdown by Technology20$502Free
Chapter- 10: Market Breakdown by Application17$427Free
Chapter- 11: Market Breakdown by Region42$1,055Free
Chapter- 12: Patent Analysis7$176Free
Chapter- 13: Competitive Landscape4$100Free
Chapter- 14: Company Profiles32$804Free
Published - Jun-2019| Analyst - Vijay Laxmi| Code - HLC176C

Report Highlights

The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.

Report Includes

  • 94 data tables and 83 additional tables
  • An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
  • Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
  • Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
  • Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
  • Coverage of new products launches and product enhancement in the industry
  • Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.
Published - Jun-2017| Analyst - Neha Maliwal| Code - HLC176B

Report Highlights

The global radiotherapy market was valued at $6.4 billion in 2016. The market should reach $6.8 billion and $9.2 billion in 2017 and 2022, respectively; growing at a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022.

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications.
  • Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.
  • Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.
  • Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
  • Comprehensive company profiles of major players in the industry.
Published - Feb-2015| Analyst - Neha Maliwal| Code - HLC176A

Report Highlights

The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in  2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%. 

Report Includes

  • An overview of the global market for radiotherapy and related technologies and applications
  • Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
  • Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
  • Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
  • Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
  • Comprehensive company profiles of major players in the industry.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS